Association for Japan Health Food Certified
JHFC
← Back to Resources

NAD+ Consumer Purchasing Guide

---

Executive Summary

NAD+ (nicotinamide adenine dinucleotide)-related dietary supplements have rapidly entered the mainstream consumer market over the past several years, with a proliferation of products appearing in Japan, China, Europe, and North America. Market expansion, however, has not been matched by consumer awareness: overclaiming is rampant, ingredient quantities are often disclosed opaquely, and raw materials of unverifiable origin fill retail shelves. This guide is written for general consumers and focuses exclusively on verifiable dimensions — selection criteria that can be assessed independently using publicly available information, without relying on any medical claims. By the end of this guide, you will be able to identify the key information on product labels, distinguish credible certifications from marketing tactics, and apply a concrete, actionable checklist to avoid common pitfalls.

---

I. Market Overview: Why You Need This Guide

The NAD+ supplement market is growing far faster than consumer literacy about it. In Japan, for example, public data from the Japan Health and Nutrition Food Association (JHNFA) shows a steady year-over-year increase in the number of health food products on the market, with NAD+ precursor categories — notably nicotinamide riboside (NR) and beta-nicotinamide mononucleotide (NMN) — emerging as among the fastest-growing segments in recent years.

A number of problems have followed:

On the supply side: The origin of raw materials is often opaque in some products, the qualifications of contract manufacturers cannot be independently verified, and in some cases the actual ingredient quantities diverge significantly from the amounts stated on the label.

On the marketing side: A large volume of advertising operates at or beyond the edge of regulatory compliance, using vague language that implies therapeutic benefits. Consumers find it difficult to distinguish between "scientific background information" and an actual efficacy claim.

On the regulatory side: Product classification and oversight vary across jurisdictions. Japan, for instance, distinguishes between Foods with Function Claims (FFC), Foods for Specified Health Uses (FOSHU), and general health foods — each tier carrying different labeling standards and levels of regulatory scrutiny.

The most practical approach for consumers is not to rely on self-reported advertising but to build a verification framework grounded in publicly available information.

---

II. Product Forms: Understanding What You're Buying

Before evaluating any specific product, consumers should understand the main forms of NAD+-related supplements available on the market. Different forms correspond to different labeling requirements and raw material sourcing pathways.

Direct NAD+ formulations: Products containing the NAD+ molecule itself. As an active coenzyme, NAD+'s stability and oral absorption pathway remain subjects of ongoing academic research. Consumers should look for products that honestly explain the formulation's characteristics and any stabilization processing — rather than making blanket absorption rate claims.

Nicotinamide Riboside (NR): A precursor form of NAD+ and a derivative of vitamin B3. Established raw material suppliers exist in major markets, and some ingredient suppliers hold relevant patents. Consumers can check product labels to determine whether the ingredient source is publicly traceable.

Beta-Nicotinamide Mononucleotide (NMN): Another NAD+ precursor. Japan's removal of NMN from its list of approved food ingredients around 2020 drew significant industry attention, prompting some brands to shift to alternative forms or reformulate their products. This regulatory change is a verifiable matter of public record. Consumers purchasing -branded NMN products should pay particular attention to the product's current regulatory compliance status.

Nicotinamide / Niacin: The basic form of vitamin B3 and a further upstream precursor in NAD+ synthesis. These have a long history of use, carry a lower cost, and are commonly found in standard multivitamin products. Some products incorporate these ingredients as "NAD+ support" components while pricing them at the premium level of NMN or NR products. Consumers should be able to recognize this substitution.

Purchasing principle: Confirm the precise chemical name of the active ingredient on the label — do not rely solely on umbrella terms such as "NAD+" to determine what you are actually buying.

---

III. Verifiable Dimension 1: Label Transparency for Ingredient Quantities

Quantity labeling is the most directly verifiable piece of information available to consumers, and also the dimension most susceptible to manipulation.

Per-serving and per-capsule quantities must be stated separately. Consumers should distinguish between the quantity per individual capsule and the total quantity corresponding to the recommended daily serving. Some products set the recommended daily serving at four capsules but state the ingredient amount on a per-capsule basis, making the number appear larger at a glance — a common visual misdirection technique.

Purity of the active ingredient. For an NMN product, for example, does the labeled NMN quantity refer to the mass of pure NMN, or does it include excipients and other components? High-transparency products typically state the purity grade or ingredient specification on the label or in accompanying documentation.

Full excipient disclosure. Japan's Health Promotion Act and the Food Labeling Act require product labels to list all ingredient names in full. Consumers should be able to see a complete ingredient list on the label — not just the primary active ingredient. Products that conceal excipients or use catch-all entries such as "other ingredients" without specifics fall short on transparency.

Lot number and expiration date management. Traceable products typically print a lot number on the packaging. This makes it possible to match third-party test reports to a specific production batch, rather than presenting test results as generic promotional materials that cannot be linked to the product the consumer is actually purchasing.

Practical tip: Compare the labeled ingredient quantities against the price to calculate the cost per milligram of active ingredient. If the price is significantly above the market average but the quantity labeling is vague or incomplete, treat that as a warning sign.

---

IV. Verifiable Dimension 2: Third-Party Testing and Certification

Third-party testing is the key mechanism for breaking the cycle of self-reported quality claims. A company can assert that its products are high quality, but an independent laboratory report constitutes external evidence that can be verified independently.

Completeness of testing scope. A credible test report should cover at minimum:

A report that only shows the primary active ingredient content while omitting heavy metals and microbiological testing is of questionable completeness.

Verifiability of the testing laboratory. The test report should clearly identify the issuing laboratory by name, along with the testing date and sample lot number. Consumers can search the laboratory's name to confirm that it is an independent, accredited facility. Reputable third-party testing laboratories operating in Japan include the Japan Food Research Laboratories (JFRL); reports issued by such institutions can be cross-checked through the institution's official channels.

Do not accept screenshots. Some brands display only partial screenshots of test reports in their marketing materials. Consumers should request access to the complete PDF or ask the brand to provide the report reference number for independent verification.

Voluntary certification schemes. In the market, the JHNFA operates a GMP Conformity Certification (GMP) program, a third-party audit and recognition scheme applied to health food manufacturing facilities. The list of certified facilities and their certification numbers is publicly available on the JHNFA's official website and can be searched by certification number. This type of certification pertains to the quality management system of the manufacturing facility — not to product efficacy. Consumers should understand this distinction clearly.

---

V. Verifiable Dimension 3: Ingredient Origin and Supply Chain Traceability

A "Made in Japan" label does not necessarily mean that the raw materials originated in Japan. Japan's Food Labeling Act sets specific requirements for country-of-origin declarations, but the disclosure requirements for ingredient origins in processed foods differ from those for agricultural produce. Consumers should proactively seek out the following information:

Raw material supplier information. The number of global raw material suppliers for key active ingredients such as NR and NMN is relatively limited. High-transparency brands typically disclose the country of origin and supplier name for their ingredients on the product page or in accompanying documentation. If a brand avoids this information entirely, its supply chain traceability should be considered questionable.

Origin is especially important for botanical extracts. Where a product contains supplementary ingredients derived from plant sources, the agricultural origin and cultivation standards of those raw materials are also part of the transparency picture.

Contract manufacturing versus in-house production. A large proportion of health food products in the market are produced under OEM (contract manufacturing) arrangements. Contract manufacturing is not inherently a quality issue — what matters is whether the brand publicly discloses information about the contract manufacturer and its certifications. Brands that conceal contract manufacturing arrangements or cannot identify the qualifications of the manufacturing facility should be rated lower on information transparency.

Additional verification for imported products. When purchasing -branded products from overseas — for example, through cross-border e-commerce platforms — consumers should confirm that the product is being sold through an authorized distribution channel and that it carries a complete label in the language of the target market. Products sold outside Japan with labels only in limit the consumer's ability to access product information, which increases the associated risk.

---

VI. Verifiable Dimension 4: GMP Certification of Manufacturing Facilities

Good Manufacturing Practice (GMP) is an internationally recognized standard for production quality management systems. In the health food sector, the core significance of GMP certification is that production process documentation, process controls, and quality testing meet standards that are auditable by a third party.

Japan's GMP framework. The JHNFA GMP Conformity Certification is one of the most credible third-party facility certification schemes in Japan's health food industry. The list of certified facilities and their certification numbers is publicly accessible on the JHNFA's official website, and consumers can look them up directly. To take certification number 34225 as an example: the facility information corresponding to that number can be confirmed on the JHNFA website — this is precisely what "verifiable" means. No trust in a brand's self-representation is required; confirmation can be obtained through an independent channel.

GMP certification is not an efficacy certification. This point bears repeating: GMP certification audits the compliance of manufacturing processes — ensuring that products are manufactured consistently to specification and that inspection records are complete. This is an entirely separate question from whether the product produces any particular health outcome. Marketing language that positions GMP certification as an endorsement of product efficacy is misleading.

ISO certifications as a supplementary reference. Some manufacturing facilities hold ISO 22000 or ISO 9001 certifications, which cover food safety management systems and general quality management systems respectively. These carry some reference value, but they address different considerations than GMP schemes specifically designed for health food manufacturing. Consumers may treat them as supplementary information rather than a primary basis for evaluation.

---

VII. Identifying Overclaiming: Language That Should Raise a Flag

The following patterns of language appear frequently in health food advertising in Japan and international markets. Consumers should treat them as signals warranting careful scrutiny.

Language that implies therapeutic effects

Numerical sleight of hand

Authority endorsement traps

Artificial urgency

Regulatory reference: Article 65 of Japan's Health Promotion Act explicitly prohibits false or exaggerated health benefit claims in food labeling and advertising. The Act against Unjustifiable Premiums and Misleading Representations similarly regulates misleading representations that cause consumers to overestimate a product's quality relative to its actual characteristics. Consumers who encounter suspected non-compliant marketing may file a report with the Consumer Affairs Agency.

---

VIII. Overview of Japan's Regulatory Framework

Understanding Japan's tiered health food regulatory system helps consumers correctly interpret product labels.

Foods with Function Claims (FFC): Companies submit scientific substantiation to the Consumer Affairs Agency (CAA). Upon acceptance of the submission, the product may carry on its label a specific function claim (limited to claims about body structure or function — not disease prevention or treatment). The CAA's public database lists all accepted submissions, including the supporting scientific literature, and is directly accessible to consumers.

Foods for Specified Health Uses (FOSHU): These products must undergo review and receive approval from the CAA. The approval standard is more rigorous than for FFCs, and the list of approved products is publicly available.

General health foods: Products in this category may not carry function claims on their labels. Compliant products in this tier should have labels that include only ingredient information, with no efficacy descriptions. If a consumer sees efficacy claims on a product in this category, that product is in all likelihood operating outside regulatory compliance.

Products outside the health function food categories: Most NAD+-related supplements are marketed as general health foods or as Foods with Function Claims. If a product has not obtained FFC status but makes specific function claims, that should prompt attention.

---

IX. Actionable Consumer Checklist

The following checks can be completed independently prior to purchase and require no specialist background.

Label review (can be done at the point of purchase)

Online verification (complete before purchasing)

Price reasonableness assessment

Sales channel assessment

---

Closing

The NAD+-related supplement category is one characterized by active scientific research interest and high consumer curiosity — as well as by a notably concentrated set of information asymmetry and overclaiming issues. The verification framework provided in this guide does not depend on any medical judgment. It is built entirely on publicly accessible information channels: regulatory agency databases, certification body websites, and product labels themselves.

A consumer's greatest protection is not trust in any particular brand's representations — it is the ability to verify information independently. Choosing products whose manufacturers are willing to provide complete, verifiable information is itself an expression of support for a culture of transparency. And transparency is the most fundamental quality guarantee a healthy market can offer.

For any decisions relating to personal health management, consultation with a licensed healthcare professional is recommended.

---

*This guide was compiled based on publicly available regulatory information from Japan and international sources. It does not constitute medical advice and does not recommend or endorse any specific product or brand. All verifiable information should be confirmed against the most current version published by the relevant authority.*

This document concerns quality/transparency only and makes no claim of pharmaceutical efficacy or disease treatment/prevention.
← Back to Resources